Published in Parkinsonism Relat Disord on July 01, 1996
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry (2002) 3.78
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Problems in assessing contents of metered dose inhalers. BMJ (1993) 3.07
Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet (1997) 2.80
Screening for diabetes in general practice: cross sectional population study. BMJ (2001) 2.64
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
Interaction of C-protein with myosin, myosin rod and light meromyosin. J Mol Biol (1975) 2.15
Psychological interventions for coronary heart disease. Cochrane Database Syst Rev (2004) 2.14
A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods. Br Dent J (2011) 2.13
IS1294, a DNA element that transposes by RC transposition. Plasmid (2000) 2.03
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J (1995) 2.02
Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens. Antimicrob Agents Chemother (1992) 1.97
Starch-Ampicillin Agar for the Quantitative Detection of Aeromonas hydrophila. Appl Environ Microbiol (1985) 1.72
Minimum standards for the management of cleft lip and palate: efforts to close the audit loop. Royal College of Surgeons of England. Ann R Coll Surg Engl (1996) 1.72
D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. J Rheumatol (1984) 1.69
The ultrastructural location of C-protein, X-protein and H-protein in rabbit muscle. J Muscle Res Cell Motil (1986) 1.67
Abnormal sulphur oxidation in systemic lupus erythematosus. Lancet (1992) 1.62
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev (1995) 1.59
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. J Hepatol (1995) 1.54
Plant moisture stress: evaluation by pressure bomb. Science (1967) 1.51
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett (1990) 1.47
Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci (1999) 1.45
Influence of surgeon's experience on speech outcome in cleft lip and palate. Lancet (1999) 1.44
Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci (2008) 1.43
Migraine after bone-marrow transplantation. Lancet (1989) 1.43
Evergreen coniferous forests of the pacific northwest. Science (1979) 1.43
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Influence of parity on fetal hemodynamics and amniotic fluid volume at term. Ultrasound Obstet Gynecol (2014) 1.37
The Pima infant feeding study: breastfeeding and respiratory infections during the first year of life. Int J Epidemiol (1984) 1.36
The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol (1970) 1.35
An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem (1994) 1.34
Word learning in the context of referential and salience cues. Dev Psychol (1999) 1.33
The proseal laryngeal mask: results of a descriptive trial with experience of 300 cases. Br J Anaesth (2002) 1.32
Submandibular duct sialolith of unusual size and shape. J Oral Surg (1975) 1.31
Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev (2003) 1.30
Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol (1984) 1.29
Adrenergic modulation of the delayed rectifier potassium channel in calf cardiac Purkinje fibers. Biophys J (1986) 1.26
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Sexual difficulties of chronic pain patients. Clin J Pain (2001) 1.25
Long-term treatment of parkinsonism with bromocriptine. Lancet (1978) 1.24
Molecular nature of a plasmid specifying beta-lactamase production in Haemophilus ducreyi. J Bacteriol (1981) 1.24
The acetylation of S-alkylcysteines by the rat. Biochem Pharmacol (1969) 1.22
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 3: speech outcomes. Cleft Palate Craniofac J (2001) 1.21
Risky single-occasion drinking amongst young people--definition, correlates, policy, and intervention: a broad overview of research findings. Alcohol Alcohol (1999) 1.19
Systematic review of outpatient services for chronic pain control. Health Technol Assess (1997) 1.19
Properties and structural role of the subunits of human spectrin. Eur J Biochem (1980) 1.18
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Xenobiotic metabolism in motor neuron disease. Lancet (1988) 1.16
Xenobiotic metabolism in Parkinson's disease. Neurology (1989) 1.16
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm (2000) 1.15
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 4: outcome comparisons, training, and conclusions. Cleft Palate Craniofac J (2001) 1.12
Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol (1990) 1.10
Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor. J Biol Chem (1984) 1.10
The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain (1994) 1.08
Carbocisteine sulphoxidation phenotype. Lancet (1990) 1.07
Campylobacter jejuni enteritis associated with raw goat's milk. Am J Epidemiol (1987) 1.06
Spinal cord stimulation and the relief of chronic pain. J Neurol Neurosurg Psychiatry (1987) 1.06
Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab (2004) 1.04
Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet (1999) 1.04
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 1: background and methodology. Cleft Palate Craniofac J (2001) 1.03
Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2003) 1.03
Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol Psychiatry (1998) 1.02
The theory of planned behaviour as predictor of exercise: the moderating influence of beliefs and personality variables. J Health Psychol (1999) 1.02
Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol Psychiatry (1999) 1.02
Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry (1988) 1.02
Understanding binge drinking among young people: an application of the Theory of Planned Behaviour. Health Educ Res (1998) 1.01
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol (1999) 1.01
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science (1979) 1.01
Smoking habits of Florida physicians revisited. JFMA (1972) 1.01
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer (1970) 1.01
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut (2005) 1.00
Growth control in the ontogenetic and regenerating zebrafish fin. Methods Cell Biol (1999) 1.00
Separation of mercapturic acids and related compounds by gas chromatography and a method for the determination of hippuric acid. J Chromatogr (1967) 1.00
Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man. Biochem Pharmacol (1982) 1.00
Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 1.00
Patients' and professionals' understandings of the causes of chronic pain: blame, responsibility and identity protection. Soc Sci Med (1997) 0.99
Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritic patients. Br J Rheumatol (1987) 0.99
Motoneurone disease as manifestation of pesticide toxicity. Lancet (1987) 0.99
Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet (1996) 0.98
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol (2001) 0.98
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology (1990) 0.98
Derepression of synthesis of the aminoacyl-transfer ribonucleic acid synthetases for the branched-chain amino acids of Escherichia coli. J Bacteriol (1974) 0.98
Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood. Dig Dis Sci (1998) 0.97
Bax inhibitor 1 in apoptosis and disease. Oncogene (2011) 0.97
Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer (1994) 0.97
Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births. Mol Reprod Dev (1998) 0.97
Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab (1989) 0.97
Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments. J Genet Couns (2007) 0.96
Are the Peer Assessment Rating Index and the Index of Treatment Complexity, Outcome, and Need suitable measures for orthognathic outcomes? Eur J Orthod (2006) 0.96
Deficient sulphoxidation status and D-penicillamine toxicity. Lancet (1983) 0.96
The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab (1992) 0.96
Health locus of control and health behaviour. J Health Psychol (1998) 0.95